Skip to main content
Caplight Logo









FemGevity

FemGevity

Private
Hoboken, New JerseyHealthcare & Life Scienceshttps://www.femgevityhealth.com/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

FemGevity operates in Healthcare & Life Sciences and is based in Hoboken, New Jersey. It was founded in 2023.

FemGevity is a digital health company that provides personalized telemedicine services, lab testing, and treatment plans for menopause and longevity care.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Subscription Commerce, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

FemGevity Comparables

Compare FemGevity with similar companies based on industry and business-model similarity.

FemGevity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evernow
86%
Winona
85%
Alloy
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

FemGevity Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for FemGevity. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Michele Wispelwey

Co-Founder, Chief Executive Officer, Founder Chief Executive Officer

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 5, 2026

    Grew 44% QoQ, from 9 to 13 employees.

  • Jul 24, 2026

    Monthly visitors grew 48% MoM, reaching 4.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

FemGevity Filings

Explore SEC and related filing metadata, where available.

FemGevity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about FemGevity's valuation, stock price, and market status.

Is FemGevity a public or private company?

FemGevity is a private company.

What is the current stock price of FemGevity?

FemGevity is a private company, so its shares have no public market price. Caplight tracks FemGevity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is FemGevity worth (valuation)?

Valuation information for FemGevity is not publicly available.

Can I buy FemGevity stock?

FemGevity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was FemGevity's last funding round?

Funding round information for FemGevity is not publicly available.

Who are the main investors in FemGevity?

Investor information for FemGevity is not publicly disclosed.

Will FemGevity IPO soon?

No public IPO plans have been announced for FemGevity.

How can I track FemGevity secondary market activity?

Caplight tracks bids, offers, and trades in FemGevity's shares on secondary markets.

Firmographic Details

HeadquartersHoboken, New Jersey
Employee Range12
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?